CEVA, Inc. (NASDAQ: CEVA), the leading licensor of wireless connectivity and smart sensing technologies which have powered more than 16 billion devices, today announced that the CEVA management...

24-Week data show TPN-101 is the first treatment for PSP to reduce NfL levels, a key biomarker of neurodegeneration in tauopathies such as PSP and Alzheimer's disease TPN-101 also showed a...

EB Research Partnership hosted the Venture Into Cures Summit alongside two Eddie Vedder shows in Seattle to support their mission of curing EB and other rare diseases. NEW YORK, Nov. 14, 2023...

Data presentations at AHA 2023 Meeting reinforce treatment with XARELTO® plus aspirin consistently reduces major cardiovascular events (MACE) as well as major adverse limb events (MALE) in...

AutoNation Mobility is offering a fully digital shopping experience with a selection of top brands and the convenience and flexibility of 6 to 12-month micro leases FORT LAUDERDALE, Fla., Nov. 14,...